The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Highlights
The global HIV Therapy Drug market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for HIV Therapy Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for HIV Therapy Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of HIV Therapy Drug include ViiV Healthcare, Gilead Sciences, Inc, AbbVie Inc., Merck & Co, GSK, Bristol-Myers Squibb Company, Theratechnologies Inc., Roche Holding AG and Teva Pharmaceuticals, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for HIV Therapy Drug in Hospital is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Multi-Type Combined Drugs, which accounted for % of the global market of HIV Therapy Drug in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for HIV Therapy Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Therapy Drug.
The HIV Therapy Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global HIV Therapy Drug market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV Therapy Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Some of the prominent players reviewed in the research report include:
- Viiv Healthcare
- Gilead Sciences, Inc
- Abbvie Inc.
- Merck & Co
- Gsk
- Bristol-Myers Squibb Company
- Theratechnologies Inc.
- Roche Holding Ag
- Teva Pharmaceuticals
- Pfizer
- Frontier Biotechnologies
- Shionogi
- Janssen Pharmaceuticals, Inc.
- Mylan Pharmaceuticals Inc.
- Genentech, Inc.
- Boehringer Ingelheim
- Cipla
- Msd
Product Type Insights
Global markets are presented by HIV Therapy Drug type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the HIV Therapy Drug are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
HIV Therapy Drug segment by Type
- Multi-Type Combined Drugs
- Nucleoside Reverse Transcription Enzyme Inhibitors
- Non-Nucleoside Reverse Transcription Enzyme Inhibitors
- Hiv Integrated Enzyme Chain Transfer Inhibitor
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the HIV Therapy Drug market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the HIV Therapy Drug market.
HIV Therapy Drug segment by Application
- Hospital
- Clinic
- Pharmacy
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina, Colombia)
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the HIV Therapy Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HIV Therapy Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of HIV Therapy Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
- This report stays updated with novel technology integration, features, and the latest developments in the market
- This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the HIV Therapy Drug industry.
- This report helps stakeholders to gain insights into which regions to target globally
- This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HIV Therapy Drug.
- This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of HIV Therapy Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of HIV Therapy Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
Index
1 HIV Therapy Drug Market Overview
1.1 Product Overview and Scope of HIV Therapy Drug
1.2 HIV Therapy Drug Segment by Type
1.2.1 Global HIV Therapy Drug Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Multi-Type Combined Drugs
1.2.3 Nucleoside Reverse Transcription Enzyme Inhibitors
1.2.4 Non-Nucleoside Reverse Transcription Enzyme Inhibitors
1.2.5 Hiv Integrated Enzyme Chain Transfer Inhibitor
1.3 HIV Therapy Drug Segment by Application
1.3.1 Global HIV Therapy Drug Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Global HIV Therapy Drug Market Size Estimates and Forecasts
1.4.1 Global HIV Therapy Drug Revenue 2017-2028
1.4.2 Global HIV Therapy Drug Sales 2017-2028
1.4.3 HIV Therapy Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 HIV Therapy Drug Market Competition by Manufacturers
2.1 Global HIV Therapy Drug Sales Market Share by Manufacturers (2017-2022)
2.2 Global HIV Therapy Drug Revenue Market Share by Manufacturers (2017-2022)
2.3 Global HIV Therapy Drug Average Price by Manufacturers (2017-2022)
2.4 Manufacturers HIV Therapy Drug Manufacturing Sites, Area Served, Product Type
2.5 HIV Therapy Drug Market Competitive Situation and Trends
2.5.1 HIV Therapy Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest HIV Therapy Drug Players Market Share by Revenue
2.5.3 Global HIV Therapy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 HIV Therapy Drug Retrospective Market Scenario by Region
3.1 Global HIV Therapy Drug Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global HIV Therapy Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America HIV Therapy Drug Market Facts & Figures by Country
3.3.1 North America HIV Therapy Drug Sales by Country
3.3.2 North America HIV Therapy Drug Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe HIV Therapy Drug Market Facts & Figures by Country
3.4.1 Europe HIV Therapy Drug Sales by Country
3.4.2 Europe HIV Therapy Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific HIV Therapy Drug Market Facts & Figures by Region
3.5.1 Asia Pacific HIV Therapy Drug Sales by Region
3.5.2 Asia Pacific HIV Therapy Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America HIV Therapy Drug Market Facts & Figures by Country
3.6.1 Latin America HIV Therapy Drug Sales by Country
3.6.2 Latin America HIV Therapy Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa HIV Therapy Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa HIV Therapy Drug Sales by Country
3.7.2 Middle East and Africa HIV Therapy Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global HIV Therapy Drug Historic Market Analysis by Type
4.1 Global HIV Therapy Drug Sales Market Share by Type (2017-2022)
4.2 Global HIV Therapy Drug Revenue Market Share by Type (2017-2022)
4.3 Global HIV Therapy Drug Price by Type (2017-2022)
5 Global HIV Therapy Drug Historic Market Analysis by Application
5.1 Global HIV Therapy Drug Sales Market Share by Application (2017-2022)
5.2 Global HIV Therapy Drug Revenue Market Share by Application (2017-2022)
5.3 Global HIV Therapy Drug Price by Application (2017-2022)
6 Key Companies Profiled
6.1 ViiV Healthcare
6.1.1 ViiV Healthcare Corporation Information
6.1.2 ViiV Healthcare Description and Business Overview
6.1.3 ViiV Healthcare HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
6.1.4 ViiV Healthcare HIV Therapy Drug Product Portfolio
6.1.5 ViiV Healthcare Recent Developments/Updates
6.2 Gilead Sciences, Inc
6.2.1 Gilead Sciences, Inc Corporation Information
6.2.2 Gilead Sciences, Inc Description and Business Overview
6.2.3 Gilead Sciences, Inc HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Gilead Sciences, Inc HIV Therapy Drug Product Portfolio
6.2.5 Gilead Sciences, Inc Recent Developments/Updates
6.3 AbbVie Inc.
6.3.1 AbbVie Inc. Corporation Information
6.3.2 AbbVie Inc. Description and Business Overview
6.3.3 AbbVie Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
6.3.4 AbbVie Inc. HIV Therapy Drug Product Portfolio
6.3.5 AbbVie Inc. Recent Developments/Updates
6.4 Merck & Co
6.4.1 Merck & Co Corporation Information
6.4.2 Merck & Co Description and Business Overview
6.4.3 Merck & Co HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Merck & Co HIV Therapy Drug Product Portfolio
6.4.5 Merck & Co Recent Developments/Updates
6.5 GSK
6.5.1 GSK Corporation Information
6.5.2 GSK Description and Business Overview
6.5.3 GSK HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
6.5.4 GSK HIV Therapy Drug Product Portfolio
6.5.5 GSK Recent Developments/Updates
6.6 Bristol-Myers Squibb Company
6.6.1 Bristol-Myers Squibb Company Corporation Information
6.6.2 Bristol-Myers Squibb Company Description and Business Overview
6.6.3 Bristol-Myers Squibb Company HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Bristol-Myers Squibb Company HIV Therapy Drug Product Portfolio
6.6.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.7 Theratechnologies Inc.
6.6.1 Theratechnologies Inc. Corporation Information
6.6.2 Theratechnologies Inc. Description and Business Overview
6.6.3 Theratechnologies Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Theratechnologies Inc. HIV Therapy Drug Product Portfolio
6.7.5 Theratechnologies Inc. Recent Developments/Updates
6.8 Roche Holding AG
6.8.1 Roche Holding AG Corporation Information
6.8.2 Roche Holding AG Description and Business Overview
6.8.3 Roche Holding AG HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Roche Holding AG HIV Therapy Drug Product Portfolio
6.8.5 Roche Holding AG Recent Developments/Updates
6.9 Teva Pharmaceuticals
6.9.1 Teva Pharmaceuticals Corporation Information
6.9.2 Teva Pharmaceuticals Description and Business Overview
6.9.3 Teva Pharmaceuticals HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Teva Pharmaceuticals HIV Therapy Drug Product Portfolio
6.9.5 Teva Pharmaceuticals Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Corporation Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Pfizer HIV Therapy Drug Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
6.11 Frontier Biotechnologies
6.11.1 Frontier Biotechnologies Corporation Information
6.11.2 Frontier Biotechnologies HIV Therapy Drug Description and Business Overview
6.11.3 Frontier Biotechnologies HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Frontier Biotechnologies HIV Therapy Drug Product Portfolio
6.11.5 Frontier Biotechnologies Recent Developments/Updates
6.12 Shionogi
6.12.1 Shionogi Corporation Information
6.12.2 Shionogi HIV Therapy Drug Description and Business Overview
6.12.3 Shionogi HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Shionogi HIV Therapy Drug Product Portfolio
6.12.5 Shionogi Recent Developments/Updates
6.13 Janssen Pharmaceuticals, Inc.
6.13.1 Janssen Pharmaceuticals, Inc. Corporation Information
6.13.2 Janssen Pharmaceuticals, Inc. HIV Therapy Drug Description and Business Overview
6.13.3 Janssen Pharmaceuticals, Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Janssen Pharmaceuticals, Inc. HIV Therapy Drug Product Portfolio
6.13.5 Janssen Pharmaceuticals, Inc. Recent Developments/Updates
6.14 Mylan Pharmaceuticals Inc.
6.14.1 Mylan Pharmaceuticals Inc. Corporation Information
6.14.2 Mylan Pharmaceuticals Inc. HIV Therapy Drug Description and Business Overview
6.14.3 Mylan Pharmaceuticals Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Mylan Pharmaceuticals Inc. HIV Therapy Drug Product Portfolio
6.14.5 Mylan Pharmaceuticals Inc. Recent Developments/Updates
6.15 Genentech, Inc.
6.15.1 Genentech, Inc. Corporation Information
6.15.2 Genentech, Inc. HIV Therapy Drug Description and Business Overview
6.15.3 Genentech, Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Genentech, Inc. HIV Therapy Drug Product Portfolio
6.15.5 Genentech, Inc. Recent Developments/Updates
6.16 Boehringer Ingelheim
6.16.1 Boehringer Ingelheim Corporation Information
6.16.2 Boehringer Ingelheim HIV Therapy Drug Description and Business Overview
6.16.3 Boehringer Ingelheim HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Boehringer Ingelheim HIV Therapy Drug Product Portfolio
6.16.5 Boehringer Ingelheim Recent Developments/Updates
6.17 Cipla
6.17.1 Cipla Corporation Information
6.17.2 Cipla HIV Therapy Drug Description and Business Overview
6.17.3 Cipla HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Cipla HIV Therapy Drug Product Portfolio
6.17.5 Cipla Recent Developments/Updates
6.18 MSD
6.18.1 MSD Corporation Information
6.18.2 MSD HIV Therapy Drug Description and Business Overview
6.18.3 MSD HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
6.18.4 MSD HIV Therapy Drug Product Portfolio
6.18.5 MSD Recent Developments/Updates
7 HIV Therapy Drug Manufacturing Cost Analysis
7.1 HIV Therapy Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of HIV Therapy Drug
7.4 HIV Therapy Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 HIV Therapy Drug Distributors List
8.3 HIV Therapy Drug Customers
9 HIV Therapy Drug Market Dynamics
9.1 HIV Therapy Drug Industry Trends
9.2 HIV Therapy Drug Market Drivers
9.3 HIV Therapy Drug Market Challenges
9.4 HIV Therapy Drug Market Restraints
10 Global Market Forecast
10.1 HIV Therapy Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of HIV Therapy Drug by Type (2023-2028)
10.1.2 Global Forecasted Revenue of HIV Therapy Drug by Type (2023-2028)
10.2 HIV Therapy Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of HIV Therapy Drug by Application (2023-2028)
10.2.2 Global Forecasted Revenue of HIV Therapy Drug by Application (2023-2028)
10.3 HIV Therapy Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of HIV Therapy Drug by Region (2023-2028)
10.3.2 Global Forecasted Revenue of HIV Therapy Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global HIV Therapy Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global HIV Therapy Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global HIV Therapy Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global HIV Therapy Drug Market Competitive Situation by Manufacturers in 2021
Table 5. Global HIV Therapy Drug Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global HIV Therapy Drug Sales Market Share by Manufacturers (2017-2022)
Table 7. Global HIV Therapy Drug Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global HIV Therapy Drug Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market HIV Therapy Drug Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers HIV Therapy Drug Manufacturing Sites and Area Served
Table 11. Manufacturers HIV Therapy Drug Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global HIV Therapy Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Therapy Drug as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global HIV Therapy Drug Sales by Region (2017-2022) & (K Units)
Table 16. Global HIV Therapy Drug Sales Market Share by Region (2017-2022)
Table 17. Global HIV Therapy Drug Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global HIV Therapy Drug Revenue Market Share by Region (2017-2022)
Table 19. North America HIV Therapy Drug Sales by Country (2017-2022) & (K Units)
Table 20. North America HIV Therapy Drug Sales Market Share by Country (2017-2022)
Table 21. North America HIV Therapy Drug Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America HIV Therapy Drug Revenue Market Share by Country (2017-2022)
Table 23. Europe HIV Therapy Drug Sales by Country (2017-2022) & (K Units)
Table 24. Europe HIV Therapy Drug Sales Market Share by Country (2017-2022)
Table 25. Europe HIV Therapy Drug Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe HIV Therapy Drug Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific HIV Therapy Drug Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific HIV Therapy Drug Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific HIV Therapy Drug Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific HIV Therapy Drug Revenue Market Share by Region (2017-2022)
Table 31. Latin America HIV Therapy Drug Sales by Country (2017-2022) & (K Units)
Table 32. Latin America HIV Therapy Drug Sales Market Share by Country (2017-2022)
Table 33. Latin America HIV Therapy Drug Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America HIV Therapy Drug Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa HIV Therapy Drug Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa HIV Therapy Drug Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa HIV Therapy Drug Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa HIV Therapy Drug Revenue Market Share by Country (2017-2022)
Table 39. Global HIV Therapy Drug Sales by Type (2017-2022) & (K Units)
Table 40. Global HIV Therapy Drug Sales Market Share by Type (2017-2022)
Table 41. Global HIV Therapy Drug Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global HIV Therapy Drug Revenue Share by Type (2017-2022)
Table 43. Global HIV Therapy Drug Price by Type (2017-2022) & (US$/Unit)
Table 44. Global HIV Therapy Drug Sales (K Units) by Application (2017-2022)
Table 45. Global HIV Therapy Drug Sales Market Share by Application (2017-2022)
Table 46. Global HIV Therapy Drug Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global HIV Therapy Drug Revenue Share by Application (2017-2022)
Table 48. Global HIV Therapy Drug Price by Application (2017-2022) & (US$/Unit)
Table 49. ViiV Healthcare Corporation Information
Table 50. ViiV Healthcare Description and Business Overview
Table 51. ViiV Healthcare HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. ViiV Healthcare HIV Therapy Drug Product
Table 53. ViiV Healthcare Recent Developments/Updates
Table 54. Gilead Sciences, Inc Corporation Information
Table 55. Gilead Sciences, Inc Description and Business Overview
Table 56. Gilead Sciences, Inc HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Gilead Sciences, Inc HIV Therapy Drug Product
Table 58. Gilead Sciences, Inc Recent Developments/Updates
Table 59. AbbVie Inc. Corporation Information
Table 60. AbbVie Inc. Description and Business Overview
Table 61. AbbVie Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. AbbVie Inc. HIV Therapy Drug Product
Table 63. AbbVie Inc. Recent Developments/Updates
Table 64. Merck & Co Corporation Information
Table 65. Merck & Co Description and Business Overview
Table 66. Merck & Co HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Merck & Co HIV Therapy Drug Product
Table 68. Merck & Co Recent Developments/Updates
Table 69. GSK Corporation Information
Table 70. GSK Description and Business Overview
Table 71. GSK HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. GSK HIV Therapy Drug Product
Table 73. GSK Recent Developments/Updates
Table 74. Bristol-Myers Squibb Company Corporation Information
Table 75. Bristol-Myers Squibb Company Description and Business Overview
Table 76. Bristol-Myers Squibb Company HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Bristol-Myers Squibb Company HIV Therapy Drug Product
Table 78. Bristol-Myers Squibb Company Recent Developments/Updates
Table 79. Theratechnologies Inc. Corporation Information
Table 80. Theratechnologies Inc. Description and Business Overview
Table 81. Theratechnologies Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Theratechnologies Inc. HIV Therapy Drug Product
Table 83. Theratechnologies Inc. Recent Developments/Updates
Table 84. Roche Holding AG Corporation Information
Table 85. Roche Holding AG Description and Business Overview
Table 86. Roche Holding AG HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Roche Holding AG HIV Therapy Drug Product
Table 88. Roche Holding AG Recent Developments/Updates
Table 89. Teva Pharmaceuticals Corporation Information
Table 90. Teva Pharmaceuticals Description and Business Overview
Table 91. Teva Pharmaceuticals HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Teva Pharmaceuticals HIV Therapy Drug Product
Table 93. Teva Pharmaceuticals Recent Developments/Updates
Table 94. Pfizer Corporation Information
Table 95. Pfizer Description and Business Overview
Table 96. Pfizer HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Pfizer HIV Therapy Drug Product
Table 98. Pfizer Recent Developments/Updates
Table 99. Frontier Biotechnologies Corporation Information
Table 100. Frontier Biotechnologies Description and Business Overview
Table 101. Frontier Biotechnologies HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Frontier Biotechnologies HIV Therapy Drug Product
Table 103. Frontier Biotechnologies Recent Developments/Updates
Table 104. Shionogi Corporation Information
Table 105. Shionogi Description and Business Overview
Table 106. Shionogi HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Shionogi HIV Therapy Drug Product
Table 108. Shionogi Recent Developments/Updates
Table 109. Janssen Pharmaceuticals, Inc. Corporation Information
Table 110. Janssen Pharmaceuticals, Inc. Description and Business Overview
Table 111. Janssen Pharmaceuticals, Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Janssen Pharmaceuticals, Inc. HIV Therapy Drug Product
Table 113. Janssen Pharmaceuticals, Inc. Recent Developments/Updates
Table 114. Mylan Pharmaceuticals Inc. Corporation Information
Table 115. Mylan Pharmaceuticals Inc. Description and Business Overview
Table 116. Mylan Pharmaceuticals Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Mylan Pharmaceuticals Inc. HIV Therapy Drug Product
Table 118. Mylan Pharmaceuticals Inc. Recent Developments/Updates
Table 119. Genentech, Inc. Corporation Information
Table 120. Genentech, Inc. Description and Business Overview
Table 121. Genentech, Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Genentech, Inc. HIV Therapy Drug Product
Table 123. Genentech, Inc. Recent Developments/Updates
Table 124. Boehringer Ingelheim Corporation Information
Table 125. Boehringer Ingelheim Description and Business Overview
Table 126. Boehringer Ingelheim HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Boehringer Ingelheim HIV Therapy Drug Product
Table 128. Boehringer Ingelheim Recent Developments/Updates
Table 129. Cipla Corporation Information
Table 130. Cipla Description and Business Overview
Table 131. Cipla HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Cipla HIV Therapy Drug Product
Table 133. Cipla Recent Developments/Updates
Table 134. MSD Corporation Information
Table 135. MSD Description and Business Overview
Table 136. MSD HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. MSD HIV Therapy Drug Product
Table 138. MSD Recent Developments/Updates
Table 139. Production Base and Market Concentration Rate of Raw Material
Table 140. Key Suppliers of Raw Materials
Table 141. HIV Therapy Drug Distributors List
Table 142. HIV Therapy Drug Customers List
Table 143. HIV Therapy Drug Market Trends
Table 144. HIV Therapy Drug Market Drivers
Table 145. HIV Therapy Drug Market Challenges
Table 146. HIV Therapy Drug Market Restraints
Table 147. Global HIV Therapy Drug Sales Forecast by Type (2023-2028) & (K Units)
Table 148. Global HIV Therapy Drug Sales Market Share Forecast by Type (2023-2028)
Table 149. Global HIV Therapy Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 150. Global HIV Therapy Drug Revenue Market Share Forecast by Type (2023-2028)
Table 151. Global HIV Therapy Drug Sales Forecast by Application (2023-2028) & (K Units)
Table 152. Global HIV Therapy Drug Sales Market Share Forecast by Application (2023-2028)
Table 153. Global HIV Therapy Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 154. Global HIV Therapy Drug Revenue Market Share Forecast by Application (2023-2028)
Table 155. Global HIV Therapy Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 156. Global HIV Therapy Drug Sales Market Share Forecast by Region (2023-2028)
Table 157. Global HIV Therapy Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 158. Global HIV Therapy Drug Revenue Market Share Forecast by Region (2023-2028)
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of HIV Therapy Drug
Figure 2. Global HIV Therapy Drug Market Share by Type in 2021 & 2028
Figure 3. Multi-Type Combined Drugs Product Picture
Figure 4. Nucleoside Reverse Transcription Enzyme Inhibitors Product Picture
Figure 5. Non-Nucleoside Reverse Transcription Enzyme Inhibitors Product Picture
Figure 6. Hiv Integrated Enzyme Chain Transfer Inhibitor Product Picture
Figure 7. Global HIV Therapy Drug Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Pharmacy
Figure 11. Global HIV Therapy Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global HIV Therapy Drug Market Size (2017-2028) & (US$ Million)
Figure 13. Global HIV Therapy Drug Sales (2017-2028) & (K Units)
Figure 14. HIV Therapy Drug Sales Share by Manufacturers in 2021
Figure 15. Global HIV Therapy Drug Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest HIV Therapy Drug Players: Market Share by Revenue in 2021
Figure 17. HIV Therapy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global HIV Therapy Drug Sales Market Share by Region (2017-2022)
Figure 19. Global HIV Therapy Drug Sales Market Share by Region in 2021
Figure 20. Global HIV Therapy Drug Revenue Market Share by Region (2017-2022)
Figure 21. Global HIV Therapy Drug Revenue Market Share by Region in 2021
Figure 22. United States HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Taiwan HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Colombia HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE HIV Therapy Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of HIV Therapy Drug by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of HIV Therapy Drug
Figure 47. Manufacturing Process Analysis of HIV Therapy Drug
Figure 48. HIV Therapy Drug Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
